The largest database of trusted experimental protocols

4 2 hydroxyethyl 1 piperazineethanesulfonic acid hepes

Manufactured by Lonza
Sourced in United Kingdom, Switzerland, Germany, United States, Belgium

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) is a chemical compound used as a buffering agent in biological research and industry. It maintains a stable pH in aqueous solutions, primarily in the range of 6.8 to 8.2. HEPES is commonly used in cell culture media, enzyme assays, and other biochemical applications where pH control is critical.

Automatically generated - may contain errors

7 protocols using 4 2 hydroxyethyl 1 piperazineethanesulfonic acid hepes

1

Cryopreserved Cell Thawing and Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following storage at −140 °C for 2 wk, isolated cells and microbeads were rapidly thawed in a 37 °C water bath24 (link),28 (link) using ice-cold Eagle’s minimum essential medium (EMEM) (EMEM; Lonza, Verviers, Belgium) as thawing media. Similarly, cryopreserved HMBs were thawed with 2% (v/v) HSA added in EMEM. Thawed hepatocytes were then plated and cultured in William’s E medium (WEM; Sigma-Aldrich) supplemented with 10% FCS (Invitrogen, Paisley, UK), 10-mM 4-(2-hydroxyethyl)-1-piperazine-ethanesulfonic acid (HEPES; Lonza), 2-mM l-glutamine (Sigma-Aldrich), 0.1-μM dexamethasone (Sigma-Aldrich), 0.1-μM insulin (Sigma-Aldrich), penicillin (50 U/mL; Sigma-Aldrich), and streptomycin (50 μg/mL; Sigma-Aldrich). Thawed microbeads were cultured in the same medium as the same as hepatocytes except Connaught Medical Research Laboratories medium (Mediatech was used, Inc., Vancouver, Canada) instead of WEM without HEPES. The cells and microbeads were maintained in a humidified incubator at 37 °C, 5% CO2 for 7 d.
+ Open protocol
+ Expand
2

Antioxidant Enzyme Activity Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
If not otherwise stated, chemicals were obtained from Sigma-Aldrich (St Louis, MO, USA). Phenol-red free Dulbecco’s Modified Eagle’s Medium (DMEM) with 4.5 g/L glucose and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) as the buffering agent (product number 12-709) was obtained from Lonza (Basel, Switzerland). The plastic and glassware used for chemical analysis were from Sarstedt (Nümbrecht, Germany). Osmium tetroxide was purchased from Agar Scientific (Stansted, UK) and epoxy resin (medium hard) from TAAB Laboratories Equipment (Aldermaston, UK). GPx and SOD assay kits were purchased from Cayman Chemical (Ann Arbor, MI, USA). All dilutions were made with high purity deionized water (18.2 MΩcm), obtained from a Milli-Q® system (EMD Millipore, Billerica, MA, USA).
+ Open protocol
+ Expand
3

Cell Culture of MRL/N-1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRL/N-1 cells were obtained from Tetsuya Kodama, Tohoku University School of Medicine, Japan. They were routinely cultured in Roswell Park Memorial Institute medium (RPMI) 1640 buffered-medium supplemented with 10% (v/v) fetal bovine serum (Dutscher), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and gentamycin (10 µg/ml; Lonza BioWhittaker). The absence of mycoplasma contamination was systematically ensured.
+ Open protocol
+ Expand
4

In vitro Expansion of Human ILC2s

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted ILC2s (100 cells/well) were expanded with human feeder PBMCs (100,000/well; 37 °C, 5% CO2) for three to five weeks. Culture medium contained RPMI 1640 Glutamax medium (Life Technologies, Darmstadt, Germany), 1% Pen/Strep (Life Technologies, Darmstadt, Germany), 10% h.i. human AB serum (Sigma-Aldrich, Taufkirchen, Germany), and 25 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, Lonza, Wakersville, USA). The medium was supplemented with 100 U/ml rh-IL-2 (Life Technologies, Darmstadt, Germany), 25 ng/ml rh-IL-4 (Miltenyi Biotech, Bergisch Gladbach, Germany), 5 µg/ml phytohemagglutinin-M (PHA-M; Sigma-Aldrich, Taufkirchen, Germany).
+ Open protocol
+ Expand
5

Engineered Fibrin Matrix Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fibrin matrices were prepared by mixing human fibrinogen (plasminogen-, von Willebrand Factor-, and fibronectin-depleted; 25 mg/mL; Enzymes Research Laboratories, Indiana, USA), fluorescent Alexa 647-conjugated fibrinogen (0.5 mg/mL; Invitrogen, California, USA), factor XIIIa (3 U/mL; CSL Behring, Pennsylvania, USA), and thrombin (6 U/mL; Sigma-Aldrich, Missouri, USA) with 2.5 mM Ca2+ in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes) (Lonza, Basel, CH). Matrices containing TG-VEGF and TG-PDG-BB were obtained by adding the engineered proteins to the cross-linking enzymes solution before mixing with fibrinogen.
+ Open protocol
+ Expand
6

SARS-CoV-2 and Influenza A Virus Propagation

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 isolate USA-WA1/2020 (NR-52281) (Biodefense and Emerging Infections Research Resources Repository, BEI Resources) was propagated in Vero-E6 cells in Dulbecco’s Modified Eagle Medium (DMEM) (Gibco) supplemented with 2% fetal bovine serum (FBS) (Millipore Sigma), 1mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (Lonza Bioscience) and 1% penicillin/streptomycin (Thermo Fisher Scientific). Virus stocks were filtered by centrifugation with Amicon Ultra-15 Centrifugal filter unit (Sigma-Aldrich) and sequenced to ensure maintenance of the furin cleavage site. Infectious viral titers were quantified by plaque assay in Vero-E6 cells (American Type Culture Collection, ATCC) in DMEM supplemented with 2% FBS, 1mM HEPES and 0.7% OXOID agar (Thermo Fisher Scientific). Assays were fixed in 5% paraformaldehyde (PFA) (Thermo Fisher Scientific) and stained with crystal violet (Sigma-Aldrich). All infections were performed with either passage 3 or 4 SARS-CoV-2. Influenza A virus H1N1 isolate A/California/04/2009 (BEI Resources) was propagated in Madin-Darby canine kidney (MDCK) (ATCC) cells in DMEM supplemented with 0.35% bovine serum albumin (BSA) (Thermo Fisher Scientific), filtered and sequenced in a manner comparable to SARS-CoV-2 stocks. All cells used in this study were routinely tested for the presence of mycoplasma using MycoAlert Mycoplasma Detection Kit (Lonza).
+ Open protocol
+ Expand
7

Chitosan Characterization and Drug Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chitosan hydrochloride was obtained from Heppe Medical GmbH, Halle, Germany. The following characteristics applied: DD 92.7%; viscosity 4-5 mPas at 1% in water at 20°C for TIM-1 studies and Ussing type rat model and DD 93.05%, viscosity 5.9 mPas at 1% in water at 20°C for Caco-2 and the inTESTine. Zovirax 200 mg dispersible tablets (GlaxoSmithKline, UK) were purchased in the Netherlands. Acyclovir was obtained from Fagron (Fagron, The Netherlands). For the Caco-2 studies, Hanks' balanced salt solution (HBSS), Dulbecco's modified Eagle's medium (DMEM), 10,000 IU/ml penicillin and 10,000 μg/ml streptomycin, nonessential amino acid medium (100 x) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were obtained from Lonza (Verviers, Belgium). Fetal bovine serum (FBS) was purchased from Biological Industries (Beit Haemek, Israel). 2-(N-morpholino)ethanesulfonic acid (MES) was obtained from Sigma-Aldrich (St. Louis, MO, United States). For rat ligated loop studies, ketamin (Ketavet, Pfizer, Germany), and xylazin (Rompun, Bayer, Germany) were obtained via the Pharmacy of the Medical Center of the Johannes Gutenberg University, Mainz, Germany. For the InTESTine study, 14 C-Antipyrine (55 mCi/mmol) was purchased from American Radiolabeled Chemicals Inc. (St. Louis, Missouri, United States).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!